Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
09/2000
09/28/2000CA2368229A1 50 human secreted proteins
09/28/2000CA2368223A1 48 human secreted proteins
09/28/2000CA2368210A1 50 human secreted proteins
09/28/2000CA2368187A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors
09/28/2000CA2368047A1 Chemokine receptor binding heterocyclic compounds
09/28/2000CA2368041A1 Indolinone compounds as kinase inhibitors
09/28/2000CA2367963A1 Hydroxamic and carboxylic acid derivatives
09/28/2000CA2367866A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000CA2367488A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000CA2367048A1 Treatment with small peptides to effect antifibrotic activity
09/28/2000CA2367025A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist
09/28/2000CA2366691A1 48 human secreted proteins
09/28/2000CA2366132A1 48 human secreted proteins
09/28/2000CA2366080A1 Prediction of diabetes impaired wound healing by urinary nitrate assay
09/28/2000CA2365255A1 Human tumor necrosis factor receptor tr9
09/28/2000CA2365247A1 49 human secreted proteins
09/28/2000CA2365243A1 Human transmembrane proteins
09/28/2000CA2365238A1 48 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/28/2000CA2364608A1 Use of vitamin c or the like for stimulating skin cell synthesis
09/28/2000CA2361221A1 Novel protein which induces chondrocyte differentiation
09/27/2000EP1038872A1 4-Phenyl-4-heteroarylpiperdine derivatives as opioid receptor ligands
09/27/2000EP1038528A1 Pentosan polysulfate containing medicament and implant for treating fibrosis
09/27/2000EP1038515A1 Composition having an aqueous phase containing l-2-oxothiazolidine-4-carboxylic acid
09/27/2000EP1038011A2 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system
09/27/2000EP1037985A1 Restin and methods of use thereof
09/27/2000EP1037983A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
09/27/2000EP1037970A1 Secreted proteins and polynucleotides encoding them
09/27/2000EP1037915A1 Matrix-remodeling genes
09/27/2000EP1037880A1 Retinoic acid mimetic anilides
09/27/2000EP1037868A2 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS
09/27/2000EP1037660A1 ribB
09/27/2000EP1037655A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
09/27/2000EP1037654A1 ribA
09/27/2000EP1037653A1 Compositions and methods for regulating phagocytosis and icam-1 expression
09/27/2000EP1037635A1 Compounds and methods
09/27/2000EP1037629A2 Combination of a retinoic acid metabolism blocking agent and a tocophereol
09/27/2000EP1037596A1 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners
09/27/2000EP0918792B1 Dipeptide benzamidine as a kininogenase inhibitor
09/27/2000CN1268130A Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
09/27/2000CN1268122A Branched alkoxy- substituted 2-aminopyridines as NOS inhibitors
09/27/2000CN1267543A Quick-healing burn and scald treating medicine powder
09/27/2000CN1267541A Psoriasis treating Chinese medicine bolus
09/27/2000CN1267528A Burn-treating medicine powder and its preparation
09/27/2000CN1267515A Composition containing at least one compound containing phenyloxime fragment
09/27/2000CN1267507A Composition containing L-2-keto thiazolidine-4-carboxylic acid in continuous aqueous phase
09/27/2000CN1056770C Qingrehuaban pills for treating psoriasis
09/27/2000CN1056758C Medicine for treatment of burn, carbuncle and ulcers and its prepn. method
09/26/2000US6124455 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
09/26/2000US6124364 Topically applying thereto, for such period of time as required to elicit the desired response, a therapeutically effective amount of at least one hydroxystilbene
09/26/2000US6124362 Topical administration of lupane triterpenes, derivatives of lupane triterpenes, derivatives of oleanane triterpenes, derivatives of ursane triterpenes, and salts
09/26/2000US6124332 Metalloproteinase inhibitors
09/26/2000US6124330 N-[4-(Heteroarylmethyl)phenyl]-heteroarylamines
09/26/2000US6124329 Metalloproteinase inhibitors
09/26/2000US6124273 Sustained release wound healing agents
09/26/2000US6124266 Sulphoquinovosyldiacylglycerol (sqdg) useful for prophylaxis or treatment of atopic dermatitis, urticaria and psoriasis, and as an antiproliferative agent
09/26/2000US6124131 Protein associated with incresed oxygen demand; for treatment and prevention of tissues damage caused by lack of oxygen
09/26/2000US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides
09/26/2000US6123959 Phospholipids, and competitive inhibitor(s) including arbutin of an enzyme for the synthesis of melanin, tyrosinase and non-competitive inhibitor(s) of tyrosinase selected from specified substituted 4-oxo-chromene compounds
09/26/2000US6123947 Herbal composition and treatment methods
09/26/2000US6123916 For treating disorders with an aetiology comprising or associated with excess of gh-secretion
09/21/2000WO2000055371A1 27 human secreted proteins
09/21/2000WO2000055352A2 50 human secreted proteins
09/21/2000WO2000055351A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000WO2000055350A1 Human cancer associated gene sequences and polypeptides
09/21/2000WO2000055332A2 Human regulators of intracellular phosphorylation
09/21/2000WO2000055321A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000WO2000055201A1 49 human secreted proteins
09/21/2000WO2000055199A1 47 human secreted proteins
09/21/2000WO2000055180A2 Human lung cancer associated gene sequences and polypeptides
09/21/2000WO2000055177A2 49 human secreted proteins
09/21/2000WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides
09/21/2000WO2000055171A1 50 human secreted proteins
09/21/2000WO2000055162A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
09/21/2000WO2000055159A2 Substituted aza-oxindole derivatives
09/21/2000WO2000055155A2 Heterocyclic compounds as adenosine deaminase inhibitors
09/21/2000WO2000055154A1 Modified amino-acid amides as cgrp antagonists
09/21/2000WO2000055153A1 Amide derivatives
09/21/2000WO2000055152A1 Aromatic heterocyclic compounds as anti-inflammatory agents
09/21/2000WO2000055141A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000055137A1 Compounds and methods for modulation of estrogen receptors
09/21/2000WO2000055127A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000055120A1 Amide derivatives
09/21/2000WO2000055118A1 Nuclear receptor arylating compounds
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000055109A1 Lipoxin compounds and their use
09/21/2000WO2000054806A1 Insulin-like growth factor binding protein-4 protease
09/21/2000WO2000054797A2 Pharmaceutical compositions comprising tgf-beta
09/21/2000WO2000054796A1 Novel antiangiogenic peptides
09/21/2000WO2000054792A1 Drugs, foods, drinks and feeds containing cocoa component
09/21/2000WO2000054780A2 Corticosteroid formulation
09/21/2000WO2000054778A1 Preventive or therapeutic agents for inflammatory dermatoses
09/21/2000WO2000054767A1 Use of lipoxin compounds for inhibiting of tnf-(alfa) initiated neutrophil response
09/21/2000WO2000054762A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
09/21/2000WO2000054743A1 Cosmetic and/or pharmaceutical preparations
1 ... 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 ... 1065